Abstract
A new series of 2-(3-chloro-2-fluorophenyl)-5-aryl-1,3,4-oxadiazole (3a–j) and 2-(aryl sulfanyl)-5-(3-chloro-2-fluorophenyl)-1,3,4-oxadiazole (5a–e) were synthesized via a multistep reaction from 3-chloro-2-fluoro benzoic acid. The newly synthesized compounds were characterized by IR, 1H NMR, 13C NMR, mass spectral data and elemental analysis. They were also screened for their in vivo anti-convulsant and anti-inflammatory activities. Some of them exhibited significant biological activities and were well supported by in silico molecular docking studies for the inhibition of cyclooxygenase-2 (PDB ID: 1CX2) and voltage-gated sodium channels (PDB ID: 4F4L) comparable with the standard drugs. Thus, they were believed to be good inhibitors of cyclooxygenase-2 (PDB ID: 1CX2) and voltage-gated sodium channels (PDB ID: 4F4L).
Similar content being viewed by others
References
P. Patrinani, S. Tacconelli, A. Bruno, C. Sostres, A. Lanas, Expert. Rev. Clin. Pharmacol. 4(5), 605–621 (2011)
M.M. Wolfe, D.R. Lichtenstein, G. Singh, N. Engl, J. Med. 340, 1888–1899 (1999)
J.W. Sander, Curr. Opin. Neurol. 16(2), 165–170 (2003)
H.P. Rang, M.M. Dale, J.M. Ritter, P.K. Moore, Textbook of Pharmacology (Churchill Livingstone, UK, 2007), pp. 575–584
S. Bansal, M. Bala, S.K. Suthar, S. Choudhary, S. Bhattacharya, V. Bhardwaj, S. Singla, A. Joseph, Eur. J. Med. Chem. 80, 167–174 (2014)
J. Grover, N. Bhatt, V. Kumar, K.N. Patel, J.B. Gondaliya, M.E. Sobhia, K.K. Bhutani, M.S. Jachak, RSC Adv. 5, 45535–45544 (2015)
P.H. Kikkeri, N.M. Kikkeri, L. Mallesha, B. Veeresh, B.M. Reddy, N.N. Kumar, Lett. Drug Des. Discov. 10(8), 783–791 (2013). doi: 10.2174/15701808113109990020
S.A. Tabatabai, S.B. Lashkari, M.R. Zarrindast, M.R. Gholibeikian, A. Shafiee, Iran. J. Pharm. Res. 12, 105–111 (2013)
N.C. Desai, M.A. Dodiya, M.K. Rajpara, M.Y. Rupala, J. Saud. Chem. Soc. 18(3), 255–261 (2014)
Y.R. Morjan, M.A. Mkadmh, E.I. Beadham, A. Adelrauof, R.M. Mattar, J. Raftery, G.P. Robin, M.A. Adel, M.G. John, Bioorg. Med. Chem. Lett. 24(24), 5790–5796 (2014)
B. Garudachari, M.A. Isloor, M.N. Satyanaraya, K. Ananda, H.-K. Fun, RSC Adv. 4, 30864–30875 (2014)
M.Y. Wani, A. Ahmad, R.A. Shiekh, J.A. Khalaf, J.F.N.S. Abilio, Bioorg. Med. Chem. 23(15), 4172–4180 (2015)
D. Dewangan, K.T. Nakhate, D.K. Tripathi, P. Kashyap, H. Dhongde, Antiinflamm, Antiallergy Agents Med. Chem. 14(3), 164–171 (2015)
S. Bajaj, V. Asati, J. Singh, P.P. Roy, Eur. J. Med. Chem. 97(5), 124–141 (2015)
D. Ega, Z. Attari, J. Mudgal, K.L. Bairy, S. Vishnuprasad, G.K. Nampurath, Indian Drugs 52(2), 40–44 (2015)
N.A. Mehta, J. Yadav, K.R. Desai, Asian J. Res. Chem. 6(5), 486–489 (2013)
K. Parikh, D. Joshi, J. Chem. Sci. 126(3), 827–835 (2014)
K.K. Jha, A. Samad, Y. Kumar, M. Shaharyar, R.L. Khosa, J. Jain, V. Kumar, P. Singh, Eur. J. Med. Chem. 45, 4963–4967 (2010)
C.R.W. Guimaraes, D.L. Boger, W.L. Jorgensen, J. Am. Chem. Soc. 127, 17377–17384 (2005)
R.M. Smith, D.L. DeWitt, R.M. Garavito, Ann. Rev. Biochem. 69, 145–182 (2000)
J.R. Vane, Y.S. Bakhle, R.M. Botting, Ann. Rev. Pharmacol. Toxicol. 38, 97–120 (1998)
D.A. Kujubu, B. Fletcher, B.C. Varnum, R.W. Lim, H.R. Herschman, J. Biol. Chem. 266, 12866 (1991)
L.J. Marnett, A. Kalgutkar, Trends Pharmacol. Sci. 20, 465 (1999)
B. Hille, Sinauer Associates Inc. (2001)
W. Stuhmer, F. Conti, H. Suzuki, X. Wang, M. Noda, N. Yahagi, H. Kubo, S. Numa, Nature 339, 597–603 (1989)
OECD guidelines for the testing of chemicals, 425 (2006)
F.C. Neuhaus, J. Mol. Graph. Model. 30, 31–37 (2011)
G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, J. Comput. Chem. 19, 1639–1662 (1998)
S.K. Kulkarni, Hand Book of Experimental Pharmacology, 3rd edn. (Vallabh Prakashan, New Delhi, 2005), pp. 128–132
V.R. Tandon, R.K. Gupta, Indian J. Physiol. Pharmacol. 49(2), 199–205 (2005)
A.M. Bhat, N. Siddiqui, A.S. Khan, Acta Pol. Pharm. Drug Res. 65, 235–239 (2008)
M. Amir, S.A. Javed, H. Kumar, Indian J. Chem. 46, 1014–1019 (2007)
C.A. Winter, E. Risley, G. Nuss, Proc. Soc. Exp. Bio. Med. 111(3), 544–547 (1962)
J. Gasteiger, M. Marsili, Tetrahedron 36, 3219–3228 (1980)
M.F. Sanner, A.J. Olson, J.C. Spehner, Biopolymers 38, 305–320 (1996)
Acknowledgments
One of the authors, Manjunatha Bhat, is grateful to the management of SeQuent Scientific Ltd., New Mangalore, India, for encouraging research work. Manjunatha Bhat is also grateful to Prof. A. Srikrishna, Department of Organic Chemistry, IISc, Bangalore, for providing 1H NMR and 13C NMR spectral facilities. We are also grateful to Dayanandsagar College of Pharmacy, Bangalore, for providing sincere help for the biological activity studies. The authors are also grateful to the Chairman, Dept. of Chemistry, Mangalore University.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bhat, M., Nagaraja, G.K., Kayarmar, R. et al. Synthesis, characterization and pharmacological evaluation of some new 1,3,4-oxadiazole derivatives bearing 3-chloro-2-fluoro phenyl moiety. Res Chem Intermed 42, 7771–7792 (2016). https://doi.org/10.1007/s11164-016-2561-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11164-016-2561-4